ReviewGigaScience2026
Unlocking the potential of Asian genomic data: a collaborative framework for precision medicine innovation.
Review in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Asian genomic datasets possess unparalleled potential to advance global understanding of human genetic diversity. Encompassing the world's largest population pool with diverse ethnicities, these datasets capture comprehensive genomic variations shaped by heterogeneous socioeconomic conditions, climate exposures, and clinical environments. However, current national genome initiatives across Asia demonstrate substantial disunity, stemming from limited cross-border communication and collaborative infrastructure, thereby diminishing their collective impact on biomedical research and precision medicine development. The MedHackathon Asia 2025 catalyzed crucial dialogues toward establishing a regional community dedicated to three pillars: harmonized biobank collaboration, standardized genomic data protocols, and cooperative governance frameworks. This multidisciplinary convening brought together researchers, clinicians, bioinformaticians, and national precision medicine program leaders from across Asia to share best practices, identify implementation challenges, and formulate foundational strategies for sustained cooperation. This community review synthesizes critical outcomes from these deliberations, emphasizing the imperative for continuous regional collaboration while advocating for the development of sustainable architectures enabling: (1) equitable biobank resource sharing, (2) genomic data standardization, and (3) ethical governance models. Through consolidation and expansion of this emerging network, Asian nations are expected to lead transformative contributions to global genomic science while ensuring appropriate representation in biomedical innovation. Such coordinated efforts promise to accelerate healthcare advancements with equitable benefits extending throughout the region and worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.